Genetic polymorphism at BCL2 as a predictor for rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone efficacy in patients with diffuse large B-cell lymphoma
oleh: Morteza Bashash, Joseph M. Connors, Randy D. Gascoyne, Barbara Meissner, Johanna M. Schuetz, Stephen Leach, Graham W. Slack, Brian R. Berry, Howard Hu, Laurie H. Sehn, Angela R. Brooks-Wilson, John J. Spinelli
| Format: | Article |
|---|---|
| Diterbitkan: | Ferrata Storti Foundation 2017-05-01 |
Deskripsi
No description available for this item.